Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_assertion description "[An expanding body of evidence indicates that downregulation of the cyclooxygenases (Cox-1 and Cox-2) will be an important strategy for preventing cancer because cyclooxygenases catalyze the formation of prostaglandins (PGs), and PGs have multiple effects that favor tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_assertion evidence source_evidence_literature NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_assertion SIO_000772 9349689 NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_assertion wasDerivedFrom befree-2016 NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_assertion wasGeneratedBy ECO_0000203 NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1382901.RAO9jQtsXPb8EO9eVh_V2swgjutdfP9-VuAbH6A5kuFyw130_provenance.